本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NovoCure Limited

13.67
-0.0800-0.58%
盤前13.22-0.4500-3.29%04:12 EST
成交量:258.27萬
成交額:3,552.97萬
市值:15.58億
市盈率:-11.19
高:14.38
開:13.55
低:13.26
收:13.75
52周最高:21.55
52周最低:9.82
股本:1.14億
流通股本:9,414.79萬
量比:0.69
換手率:2.74%
股息:- -
股息率:- -
每股收益(TTM):-1.2221
每股收益(LYR):-1.2221
淨資產收益率:-38.89%
總資產收益率:-9.06%
市淨率:4.58
市盈率(LYR):-11.19

資料載入中...

2026/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/11

重要事件披露

Form 8-K - Current report
2026/02/05

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/01

重要事件披露

Form 8-K - Current report
2025/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/09/15

重要事件披露

Form 8-K - Current report
2025/08/28

重要事件披露

Form 8-K - Current report
2025/07/24

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/24

重要事件披露

Form 8-K - Current report
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments